Biotts
PrivateLast Round
Accelerator
Oct 5, 2021
Total Funding Raised
$3.64M
Company Overview
Biotts is a Poland-based biotechnology company that develops proprietary drug delivery technologies and drug formulas in the fields of oncology, dermatology, and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biotts Comparables
Compare Biotts with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anodyne Nanotech | 85% | |
| Dyve Biosciences | 79% | |
| Axcelead, Inc. | 77% | |
Biotts Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 5, 2021 | ||||
| VC Round | Mar 22, 2020 | ||||
| Grant | Dec 20, 2019 | ||||
| Grant | Aug 1, 2018 |
Key People
Founding team and executive leadership
Biotts Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Montis Capital | Grant |
| Google for Startups Accelerator | Accelerator |
| Montis Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 3, 2026
Monthly visitors grew 152% MoM.
- Mar 2, 2026
Monthly visitors increased 282% MoM.
Biotts Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biotts's valuation, stock price, and market status.